Romaco: System Solution with Patented In-Line Scale
At the forthcoming POWTECH 2014, Romaco Kilian will show the Kilian KTP 420X tablet press with the patented in-line continuous weight control (CWC). The engineering specialist’s new KTP 420X series is an innovative generation of flexible, high speed tablet presses for the pharmaceutical industry.
The Romaco Kilian KTP 420X is a versatile, high speed tablet press which, in combination with the new CWC system, will be Romaco’s highlight at this year’s POWTECH. This groundbreaking machine, equipped with numerous patented features, compresses up to 360,000 tablets an hour. The Kilian KTP 420X is ideal for the production of mono-layer, bi-layer or core tablets (tab-in-tab), and it can also be used to process poorly flowing materials. It is characterised by high effective availability, low costs for maintenance and spare parts and very simple handling. The Kilian KTP 420X is winner of this year’s iF Award for innovative design.
Patented Features
The patented CWC in-line scale allows the weight of the tablet being produced to be measured continuously at the discharge as the products are pressed without destroying them. The KTP 420X makes Romaco Kilian the first manufacturer worldwide to offer a solution for continuous weight control. The weighed tablets are placed in the “good” channel using compressed air. As a result of the new process, there is no longer any need to make sample tablets to check the weight and product loss is reduced to zero. This automatic weight control system helps to avoid unnecessary costs, especially when processing expensive (active) ingredients.
One tablet is measured per turret revolution with an accuracy of 0.1 mg. The CWC system is fully integrated in the PLC and operated over the HMI (human machine interface) panel. The results of the measurements can be leveraged directly to control the machine and greatly improve the reliability of the process. CWC can be supplied as an option for all models in the KTP 420X and KTP 720X series and is also available as a retrofit kit.
High Flexibility and Low Total Cost of Ownership
The wear-free torque motor, extremely durable compression rollers and wear-free lower punch brakes with patented magnets underlie the very low total cost of ownership. The likewise patented punch bellows protect the tablets from lubricants. Thanks to the hermetic separation of the compaction and service areas, no product or oil gets into the machine compartment of the press. The optimised hygienic design permits quick and easy cleaning. At the same time the new, ergonomic, Windows 7 based HMI panel guarantees reliable handling. The significant reduction in press noise adds to the user friendly working environment.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance